Mind Medicine

Mind Medicine in its successful proxy contest against FCM MM Holdings, LLC


Mind Medicine




Corporate and Securities Litigation

Date Closed

June 2023



Lead Office



Osler advised Mind Medicine (MindMed) Inc. on its successful proxy contest against FCM MM Holdings, LLC. MindMed announced that, based upon a preliminary vote assessment, shareholders have elected all six of MindMed’s nominees to the board of directors at the annual general meeting of shareholders held on June 21, 2023. FCM MM Holdings, LLC represented certain dissident shareholders including co-founder Dr. Scott Freeman sought to replace four of the six directors on MindMed’s board.

Mind Medicine is a clinical-stage biopharmaceutical company dual listed on NASDAQ and Cboe Canada.

Osler, Hoskin & Harcourt LLP advised Mind Medicine with a team consisting of Trevor Scott, Andrew MacDougall, Minji Park (Corporate) and Teresa Tomchak (Litigation).